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SUMMARY
1. Natural killer cell activity and m onocyte cyto­
toxicity was evaluated in three subgroups of patients with 
primary hypogam m aglobulinaem ia (ten patients with late- 
onset. eight with X-linked and five with early-onset 
disease) and in two patients with secondary  late-onset 
hypogamm aglobulinaemia against the K-562 erythro- 
leukaemia, the C aC o-2  colon carcinom a and the HGT-1 
gastric carcinom a cell lines and com pared  with the results 
found in healthy control subjects.
2. T h e  natural killer cell activity, both spontaneous 
and after stimulation with recom binant y-interferon, was 
found to be decreased  in patients with late-onset hypo­
gammaglobulinaemia. T h e  natural killer ccll activity in 
this subgroup was found to be impaired in 60%  of the 
patients (P<  0.05). Within the o ther  forms of primary 
hypogam m aglobulinaem ia a decreased natural killer cell 
activity was found to be less frequent (33%).
3. T h e  lectin-mediated cytotoxicity by phytohaem - 
agglutinin resulted in a similar maximal cytotoxicity in 
patients and control subjects.
4. T h e  cytotoxicity of monocytes, spontaneous and 
after recom binant y-interferon stimulation, was found to 
be normal in all patients with hypogammaglobulinaemia.
5. T h e  impaired natural killer cell activity which was 
found in patients with late-onset hypogam m aglobulin­
aemia may contribute  to the increased susceptibility to 
infections and to the increased incidence of malignancies 
in this subgroup of patients with primary hypogam m a- 
elobulinaemia.
Abbreviations: ry-IFN , recom binant y-interferon; NK. 
natural killer; PH A , phytohaemagglutinin.
Key words: cytotoxicity, hypogammaglobulinaemia, y- 
interferon, monocytes, natural killer cells.
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INTRODUCTION
Primary hypogammaglobulinaemia, especially in its late- 
onset form, is associated with im pairm ents of not only 
humoral but also of cellular immune responses [1, 2]. 
Several studies indicated that these patients have an 
increased incidence of malignancies; in particular, 
patients with late-onset hypogammaglobulinaem ia have 
an increased chance of developing non-H odgkin 
lym phom a and a 50-fold increased chance of developing 
stomach cancer [3-5]. Natural killer (NK) cells are part of 
the natural immune system and play a role in the resist­
ance against virus-infected cells and tum our cells [6]. 
Studies on NK cell activity in primary im m unodeficien­
cies have been scarce and inconclusive, i.e. both normal 
and incidentically decreased NK cell activity have been 
found. However, a majority of the studies indicate that 
within the group of patients with com m on variable hypo­
gammaglobulinaemia some patients show decreased NK 
cell activity, but in this regard no subpopulations of 
patients could be defined (Table 1 [7-13]).
In the present study w'e m easured the NK cell activity 
and m onocyte cytotoxicity in well-defined subgroups of 
patients with primary hypogammaglobulinaemia. C yto­
toxicity, both spontaneous and after stimulation with 
recom binant y-interferon and the lectin phy tohaem ­
agglutinin (PHA), was determ ined  against lymphoid and 
gastrointestinal cell lines.
MATERIALS AND METHODS 
Patients and control subjects
Twenty-three patients with primary hypogam m a­
globulinaemia were studied. Ten patients with late-onset 
hypogamm aglobulinaemia (four females and six males.
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Table 1. NK cells in hypogammaglobulinacniia
Abbreviations: C V H , com m on variable hypogammaglobulinaemia; IgA def, selective IgA 
deficiency; XLA, X-linked agammaglobulinaemia; CVA, com m on variable agammaglobulin- 
aemia; CVI, com m on variable immunodeficiency; SCID, severe com bined immunodeficiency; Ig,
immunoglobulin.
Reference Immunodeficiency (no. of patients) NK cell observation
Sirianni et al. [7] 
Koren et al. [S] 
Messina et al. [9] 
Gupta [10] 
Lipinski et al. [Il ] 
Peter et al. [12] 
Clerici et al. [13]
IüA def ( 10). CVH (5), XLA (3) 
CVA (6), XLA (5)
CVI (31 )
CVI (8), IgA def (4), XLA ( 1 ) 
CVI (5), XLA (2), IizA def ( 1 ) 
SCID, low Ig levels (8)
CVH ( 1 )
Normal activity 
Normal activity
Normal to decreased activity; no subgroups 
Decreased numbers (eight out of 1 3 patients) 
Decreased activity (50% of patients) 
Decreased activity (six out of eight patients) 
Decreased activity
•
mean a^e 38 years, ran«e 17-68  years), eight patients 
with X-linked hypogammaglobulinaemia (eight males, 
mean age 25 years, range 17-37  years), five patients with 
early-onset hypogammaglobulinaemia (one female and 
four males, mean age 24 years, range 19-31 years) and 
two patients with secondary hypogammaglobulinaemia 
due to a lymphoproliferative cancer (two males with 
multiple myeloma, mean age 67 years, range 5 7 -7 8  
years). All patients had reduced or absent serum y- 
globulin levels and treatment consisted of supple­
mentation with y-globulin an d /o r  administration of 
antibiotics.
T he  criteria used for the diagnosis of primary hypo­
gammaglobulinaemia were for X-linked hypogam m a­
globulinaemia the onset of clinical signs during the first 2 
years of life, a family history compatible with an X-linked 
pattern of inheritance, and absence or profound decrease 
of B-lymphocytes in the peripheral blood or bone 
marrow. In patients in whom clinical symptoms began 
before the age of 2 years but no evidence for X-linked 
inheritance was found, the diagnosis of early-onset hypo­
gammaglobulinaemia was made. In these patients, 
B-lymphocytes were either absent, scarce or present in 
normal numbers. Patients were considered to have late- 
onset hypogammaglobulinaemia if clinical manifestations 
began after the age of 10 years and B-lymphocytes, but 
not plasma cells, were found in the bone m arrow [1,2].
T he  control subjects consisted of 25 healthy volunteers 
(nine females and 16 males, mean age 36 years, range 
2 2 -5 8  years), none of whom had signs of im m uno­
deficiency o r  recurrent infection.
Peripheral blood mononuclear cells
M ononuclear cells were obtained by F ico ll-H ypaque  
density gradient centrifugation of heparinized peripheral 
blood. Part of the total m ononuclear ccll suspension was 
used in the cytotoxicity assay without further purification, 
while the o ther part was separated in lymphocytes and 
monocytes by élutriation centrifugation by a previously 
described technique [ 13]. T he  viability of these fractions, 
determ ined by Trypan Blue exclusion, was more than 
98%. T h e  fractions were kept in RPM1 1640 medium 
supplem ented with 2 mM-glutamine, penicillin ( 100 units/
ml), streptomycin (100 / /g/ml), gentamycin (50 /¿g/ml), 
am photericin B (2.5 /¿g/ml) and 10% (v/v) fetal calf 
serum. T h e  composition and purity of the ccll fractions 
were evaluated by cell identification on cytospins with a 
M ay-G riinw ald/G iem sa stain and non-specific esterase 
staining for monocytes in the cell suspensions. T h e  purity 
of the lymphocyte fraction was usually above 98%, 
whereas for monocytes this was found to be greater than 
80%. M onocyte purity was further increased to above 
95%  by 90 min adherence in 96-well culture plates and 
removal of the non-adhered  cells by three washings with 
culture medium.
Cytotoxicity assay
T h e  cytotoxicity assay was perform ed as previously 
described [ 14|. Effector cells, i.e. total m ononuclear cells, 
and separated  lymphocytes and monocytes were cultured 
for 24 h at 37°C in a 5% C O : /9 5 %  air mixture in culture 
medium to reverse any possible adverse effects of the 
isolation process before functional assay. T h e  target cells 
used were the erythroleukaem ia cell line K-562, the 
human colon cancer cell line C aC o-2  and the human 
gastric carcinom a cell line HGT-1 [15]. T h e  K-562 and 
HGT-1 cell lines were cultured in RPMI 1640 medium 
supplem ented with 10% (v/v) fetal calf serum, CaCo-2  
with 20%  (v/v) fetal calf serum and antibiotics, and were 
kept in growth phase by transferring 1:3 twice a week. 
T he  target cells were harvested and labelled with 
N a2MCrO^ (100 /¿ C i /5 x  1()() cells; N E N  D upont, West 
Germ any) for 1 h at 37°C. T h e  effector to target ratio 
used for all populations was 50:1; for the monocytes the 
num ber of plating cells was adjusted to the 2.5 x 106/ml 
non-specific esterase positive cells. Recom binant y-inter­
feron (ry-IFN; Boehringer, Ingelheim, West Germ any) 
and PH A  (Wellcome Research, Beckenham, Kent, U.K.) 
were dissolved in culture medium. T he  assay concen tra­
tion for ry-IFN  was 500 units/ml added  at the start of the 
24 h preincubation period. T he  concentration of PHA 
was 1 /¿g/ml. T he  assay was perform ed in triplicate with a 
final volume of 200 //1/well. A fter the target cells were 
added, the plates were centrifuged for 5 min at 500  # a n d  
incubated for 18 h at 37°C in a 5% C O : /9 5 %  air a tm o­
sphere. A fter 18 h incubation the supernatant was
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collected by a harvesting system (Supernatant Collection 
System; Skatron AS, Licr, Norway). T h e  released label 
was counted in a y-counter. T h e  spontaneous release was 
determ ined by incubation of the target cells with culture 
medium, ry-IFN  or PH A  and the maximal release by 
incubation of the targets with saponin. Cellular cyto­
toxicity was calculated by using the following formula:
Cytotoxicity (%) =
experimental release -  spontaneous release 
maximal release — spontaneous release
x 100
T he  cytotoxicity assay for all cell populations, i.e. total 
m ononuclear cells and the enriched lymphocytes and 
monocytes, was for uniformity perform ed as an 18 h 
assay. T h e  specificity of the 18 h cytotoxicity assay for 
NK cells was determ ined by com plem ent lysis of Leu 1 1 
(CD 16) monoclonal antibody coated m ononuclear cells 
in four experiments. Inhibition of the 18 h cytotoxicity 
was above 85%  both for K-562 and for CaCo-2.
Statistical analysis
All data  are expressed as means ± sem. T he  statistical 
significances of the differences were evaluated with the 
non-param etric  two-tailed Wilcoxon's rank-sum and the 
/- '-F isher 's  exact tests.
R E SU L T S
T h e  spontaneous NK cell activity showed a tendency to 
be decreased in the total group of patients with primary 
hypogam maglobulinaemia only against the K-562 targets 
( / , =  0.056). W hen divided into subgroups, only patients 
with late-onset hypogammaglobulinaemia were found to
have a significantly impaired NK cell activity (P<  0.05) 
against the K-562 targets; the NK cell activity against the 
C aC o-2  and HGT-1 was similarly impaired, although the 
differences failed to reach statistical significance (Table 2). 
W hen 50%  cytotoxicity was used as the lower limit of 
normal, 60%  of the patients with late-onset hypogam m a­
globulinaemia (six out of ten) were found to have low 
levels of NK cell activity (P<  0.05), whereas in X-linked 
(four out of eight; 50%), in early-onset (one out of five; 
20%) and in secondary late-onset hypogammaglobulin­
aemia (none out of two; 0%) NK cell activity was not sig­
nificantly different when com pared  with the control 
subjects (one out of 19; 5%) (Fig. 1). No differences were 
found in any of the clinical param eters (age, sex, duration  
of illness and treatments) between patients with decreased 
NK cell activity and those without.
Lectin-m ediated cytotoxicity by PHA resulted in a 
significant increase in the cytotoxicity of the total m ono­
nuclear cells of all patients and control subjects (all 
groups P<  0.05), irrespective of the underlying disease or 
the target cell line used, towards a maximal cytotoxicitv 
level of 7 5 -8 0 % .
ry-IFN also stimulated the NK cell activity sub­
stantially (all groups />< 0 .05 ). However, this stimulation 
did not overcom e the deficient spontaneous cytotoxicity 
found in the patients with late-onset hypogammaglobulin­
aemia (Table 2).
Studies with the enriched lymphocytes from patients 
and control subjects, obtained by élutriation centrifuga­
tion, showed a similar pattern in the spontaneous and 
stimulated cytotoxicity revealing a lower NK cell response 
in patients with late-onset hypogammaglobulinaemia 
(data not shown).
Purified monocytes, both from patients and control 
subjects, hardly showed any spontaneous cytotoxic 
activity against each of the cell lines used. Stimulation
Table 2. NK cell activity, spontaneous and after stimulation with ry-IFN, of total mononuclear
cells from patients with hypogammaglobulinaemia and control subjects
Results arc means ±sem  with n in parentheses. Statistical significance: :57 >= 0.056, **P<()A)5
com pared  with controls.
Cytotoxicity (%)
Target cells... K-562 CaCo-2 HGT-1
Spontaneous
Controls 64.0 ±3.2(19) 38.6 ±4.5(23) 53.2 ±6.7(13)
Hypogammaglobulinaemia
Primary (total) 54.1 ±3.8*(23) 35.0 ±3.8(19) 42.9 ±4.2(22)
Late-onset 49.6±6.I**(I0) 27.0 ± 5.1(7) 36.8 ±7.1(9)
Early-onset 66.4 ±7.7(5) 41.6 ±9.6(5) 53.2 ±9.7(5)
X-linked 52.0 ±5.5(8) 38.3 ±5.7(7) 43.4 ±5.8(8)
Secondary 71.5 ±6.5(2) 57.6 ± 15.9(2) 61.7 ± 17.8(2)
Stimulation with ry-IFN
Controls 7 1.4 ±2.4(19) 55.2 ±4.7(20) 64.6 ± 5.5( 1 3)
Hypogammaglobulinaemia
Primary (total) 61.0±3.4**(22) 47.3 ±4.5(18) 55.5 ±4.5(21)
Late-onset 57.4±5.2**(9) 36.6 ± 5.3**(6) 49.1 ±7.1(8)
Early-onset 69.7 ±7.0(5) 52.4 ± 10.6(5) 60.2 ± 10.5(5)
X-linked 59.6 ±6.0(8) 52.8 ±7.2(7) 58.9 ±7.5(8)
Secondary 73.4 ±3.6(2) 70.9 ± 12.3(2) 73.3 ±8.8(2)
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Fig. 1. Spontaneous NK cell activity of patients with 
hypogammaglobulinaemia and control subjects against 
the K-562 cell line. Bars indicate means. *. Control sub­
jects: •  . late-onset hypogammaglobulinaemia; o , X-linked 
hypogammaglobulinaemia; ★. early-onset hypogamma- 
globulinacmia; ■ , secondary hypogammaglobulinaemia. 
T he  broken line indicates the lower normal range of spon­
taneous NK cell activity.
Table 3. Spontaneous and ry-IFN-stinmlated cytotoxicity 
of peripheral blood monocytes from patients with hvpo- 
gamniaglobulinaeniia and control subjects against K-562
targets
Similar
H G T-1
results were obtained with the C aC o-2  
cell lines. Results are m e a n s ± s e m  with
parentheses.
and 
n in
Subjects Cytotoxicity (%)
Spontaneous Stimulation with 
ry-IFN
Controls 4 .1 ± l.5( I 7) 16.3 ±3.3(17)
Hy p oga m m agi o bu l i n ae m i a
Primary (total) 3.4 ± 1.1(21) 12.5 ±2.1(21)
Late-onset 4.5 ±2.0(8) 15.6 ±3.0(8)
Early-onset
J
5.2 ± 1.8(5) 1 1.3 ± 4.1(5)
X-linked 1.3 ± 1.8(8) 10.2 ±4.0(8)
with ry-IFN increased the monocyte-m ediated cyto­
toxicity significantly (all groups P<0X)5)  with no dif­
ferences between patients, subgroups or patients and 
control subjects, nor between the three target cell lines 
used (Table 3).
DISCUSSION
In the present study we evaluated the NK cell activity in 
patients with primary hypogammaglobulinaemia. Patients 
with late-onset hypogammaglobulinaemia were found to 
have a significant decreased NK cell activity, both spon­
taneous and after stimulation with ry-IFN , whereas such 
an impairment was less prom inent in patients with o ther 
forms of primary hypogammaglobulinaemia and absent in 
second a ry h y pogam m agio bu 1 i nae m i a .
Previous reports  on NK cell activity in primary hypo­
gammaglobulinaemia were not conclusive with regard to 
disease-related differences. Some studies describe a 
normal NK cell activity |7, 8], whereas others show 
decreased NK cell activity or NK cell num bers in hypo­
gammaglobulinaemia patients without the identification 
of subgroups of patients [9-13]. In ou r  study we also 
found a normal NK cell activity in the total group of 
patients with primary hypogammaglobulinaemia. 
Remarkably, however, both Gupta 110) and Lipinski ct nl. 
1 11 found that in the subgroup of late-onset hypogam m a­
globulinaemia patients NK cell num bers o r  activity were 
low (respectively three out of eight, and two out of four 
patients). We found similar num bers of patients with 
decreased NK cell activity in the subgroup of patients 
with late-onset hypogammaglobulinaemia (six out of ten 
patients). In the patients with o ther  forms of hypogam m a­
globulinaemia, a decrease in NK cell activity was found 
less frequently in our study, which corresponds with 
previous reports [7, 8]. However, the num ber of patients
studied were small which limited statistical analysis of the
« /
frequency of this phenom enon  in these subgroups. T he  
decrease in NK cell activity of late-onset hypogam m a­
globulinaemia patients in our study was not target
C- I ^ C
specific, since it was noticed against the s tandard  NK cell 
line K-562 but also against the colorectal cancer C aC o-2CT
and the gastric cancer HGT-1 cell lines. This  is especially 
interesting since patients with late-onset hypogam m a­
globulinaemia have an increased incidence of non- 
Hodgkin lymphoma and gastric cancer |3, 4|. Thus, the 
decreased NK cell activity may identify late-onset hypo­
gammaglobulinaemia as a pre-malignant condition. Inter­
estingly, a completely different study by ou r  group on the 
gastrin response to bombesin stimulation in primary 
hypogammaglobulinaemia, also identified the late-onset 
hypogammaglobulinaemia patients as a high cancer risk 
subgroup 116]. Prospective and follow-up studies need to 
be performed to determ ine whether the susceptibility for 
malignancy is especially increased in the patients with 
reduced NK cell activity and reduced plasma gastrin 
response to bombesin stimulation.
We found a normal response of the NK cells to ry-IFN 
which did not overcom e the decreased spontaneous NK 
cell activity in the patients with late-onset hypogam m a­
globulinaemia. T hese  findings correspond  to previous 
reports in which both the production of and the response 
to interferon in hypogammaglobulinaemia patients was 
found to be normal |9. 1 11.
Hypogammaglobulinaemia patients showed a normal 
lectin-mediated cytotoxicity with no difference between
•> J
the subgroups. T here  is only one o ther study, by Lubens 
ct til. 117), which showed that two patients with hypo­
gammaglobulinaemia also had a normal PHA-induced 
cytotoxic response, therefore indicating that the synthesis 
of interleukin-2 and its receptor, which is mediated by 
PHA. is fully intact in patients with primary hypo- 
ga m m agio b u 1 i n ae m i a .
Monocytes, known to have cytotoxic capabilities 118 
showed a normal spontaneous and ry-IFN -induced  cyto­
toxicity in patients with primary hypogammaglobulin-
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acmia which indicates that they do  not contribute to the 
deficient cytotoxic response of patients with late-onset 
hypogammaglobulinaemia.
In conclusion, a majority of patients with late-onset 
hypogam maglobulinaemia have an impaired NK cell 
activity against several tum our cell lines. Stimulation with 
ry-IFN and PH A results in a normal response in these 
patients. O ther  forms of primary hypogammaglobulin­
aemia have a lower frequency of the impairment of NK 
cell activity. T he  relevance of these findings with regard to 
the high incidence of gastric cancer in late-onset hypo­
gammaglobulinaemia has yet to be established.
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